Jonathan Fritz Barnett, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 725 Welch Rd, Palo Alto, CA 94304 Phone: 650-497-8000 |
Dr. Michael K Hung, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 795 El Camino Real, Palo Alto, CA 94301 Phone: 650-853-2894 |
Rita Agarwal, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 725 Welch Rd, Palo Alto, CA 94304 Phone: 650-497-8000 |
Dr. Lauren Emery Smith, MD Anesthesiology - Pediatric Anesthesiology Medicare: Medicare Enrolled Practice Location: 725 Welsh Rd, Palo Alto, CA 94304 Phone: 650-497-8000 |
Andrea Joy Murray, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 725 Welch Rd, Palo Alto, CA 94304 Phone: 650-497-8000 |
Allegra Eliot Lobell, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 300 Pasteur Dr, Stanford Hospital Dept Of Anesthesia, Palo Alto, CA 94305 Phone: 650-723-4000 |
Dr. Maytinee Lilaonitkul, MBBS, BSC Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 300 Pasteur Dr, Department Of Anesthesiology, Stanford, Palo Alto, CA 94305 Phone: 650-723-5024 |
Dr. Frank Sarnquist, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 2680 Hanover St, Palo Alto, CA 94304 Phone: 650-498-7103 |
Helen Evans, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 795 El Camino Real, Palo Alto, CA 94301 Phone: 650-853-2894 |
Kristin Anne Sun, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 725 Welch Rd, Palo Alto, CA 94304 Phone: 650-497-8000 |
Dr. Eve Eames Nyrhinen, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 725 Welch Rd, Palo Alto, CA 94304 Phone: 650-497-8000 |
Kurt A Fink, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 795 El Camino Real, Palo Alto, CA 94301 Phone: 650-321-4121 |
Dr. Steven Keith Howard, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 3801 Miranda Ave, Anesthesia Service 112a, Palo Alto, CA 94304 Phone: 650-858-3938 |
Dr. Shirley Liu, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 795 El Camino Real, Palo Alto, CA 94301 Phone: 650-853-2894 |
Caroline Anne Yeldezian, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 3801 Miranda Ave, Palo Alto, CA 94304 Phone: 650-493-5000 |
Richard Hunter, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 795 El Camino Real, Palo Alto, CA 94301 Phone: 650-321-4121 |
Kelly Anne Fedoruk, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 725 Welch Rd, Palo Alto, CA 94304 Phone: 650-497-8000 |
Joseph Weber, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 795 El Camino Real, Palo Alto, CA 94301 Phone: 650-321-4121 |
Dr. Jonathan Bradley, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 795 El Camino Real, Palo Alto, CA 94301 Phone: 650-853-2894 |
James Joseph Fehr, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 725 Welch Rd, Palo Alto, CA 94304 Phone: 650-497-8000 |
News Archive
A new study that looked at the hunger trends over a 10-year period found that 14.85 percent of seniors in the United States, more than one in seven, face the threat of hunger. This translates into 8.3 million seniors.
Giving antimalarial medicines to children monthly during the rainy season cut malaria deaths in children by 42 per cent, making a case for wide implementation in malaria-endemic African regions, a study found.
A gene thought to be associated with cancer development can be a tumor suppressor gene in mice, researchers have discovered. Understanding which genes are involved in spreading cancer could lead to future therapies.
Bio-Path Holdings, Inc., a biotechnology company developing a liposomal delivery technology for nucleic acid cancer drugs, today announced that it has received a grant of $244,479 from the United States Government to help fund the Company's Phase I clinical trial of its lead cancer drug candidate Liposomal Grb-2. The amount of funds awarded was the maximum allocation allowed under the program.
› Verified 5 days ago